Dr. Lal Pathlabs Ltd.
NSE: LALPATHLAB | BSE: 539524
₹1,631.50
₹-49.30
(-2.93%)
As on 22-May-2026 13:29IST
Market cap
₹27,519 Cr
Revenue (TTM)
₹2,763 Cr
P/E Ratio
54.5
P/B Ratio
11
Div. Yield
1.2 %
Quality Score
10/10
Growth Score
6/10
Valuation Score
4/10
Momentum Score
2/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹505 Cr
-
ROE
25.2 %
-
ROCE
31.5 %
-
Industry P/E
55.79
-
EV/EBITDA
30.1
-
Debt to Equity
0
-
Book Value
₹149.6
-
EPS
₹48.3
-
Face value
10
-
Shares outstanding
167,637,770
10 Years Aggregate
CFO
₹3,434.43 Cr
EBITDA
₹4,138.09 Cr
Net Profit
₹2,631.02 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dr. Lal Pathlabs
| 10.0 | 13.5 | 16.3 | 15.1 | 18.9 | 2.9 | 12.8 |
|
BSE Healthcare
| 9.5 | 9.4 | 10.3 | 11.6 | 27.8 | 14.2 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Dr. Lal Pathlabs
| -2.9 | 16.5 | 14.0 | -40.9 | 58.8 | 50.3 | 61.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dr. Lal Pathlabs
|
1,631.5 | 27,519.4 | 2,762.9 | 509.8 | 22.5 | 21.5 | 54.5 | 11.0 |
| 760.3 | 39,579.3 | 4,643.2 | 464.1 | 13.7 | 8.9 | 102 | 8.6 | |
| 478.1 | 15,209.2 | 2,080.1 | 168.1 | 14.1 | 6.7 | 114.2 | 7.5 | |
| 1,242.7 | 33,302.7 | 4,410.2 | 554.1 | 15.8 | 14.5 | 59.8 | 8.4 | |
| 769.7 | 30,866.7 | 3,904.6 | 239.4 | 13.3 | 11.1 | 127.9 | 13.7 | |
| 519.2 | 10,884.9 | 1,645.9 | 191.2 | 16.2 | 13.3 | 57.3 | 7.2 | |
| 466.9 | 7,421.9 | 829.0 | 161.5 | 24.5 | 30 | 45.5 | 12.7 | |
| 1,228.9 | 12,663.5 | 814.2 | 173.0 | 30.1 | 19 | 73.2 | 13.2 |
Shareholding Pattern
View DetailsNews & Analysis
All News
The Backing of a Resilient Balance Sheet
5 min read•By Jugal Harpalani
About Dr. Lal Pathlabs
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology,... electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India. Read more
-
Incorporated
1995
-
Chairman
Arvind Lal
-
Managing Director
--
-
Group
Arvind Lal
-
Headquarters
New Delhi, Delhi
-
Website
Looking for more details about Dr. Lal Pathlabs Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsAGM To Be Held On July 25 2026
30-Apr-2026No News & Announcements are available.
FAQs for Dr. Lal Pathlabs
What is the current share price of Dr Lal Pathlabs Ltd Today?
The share price of Dr Lal Pathlabs Ltd is ₹1,631.50 (NSE) and ₹1,633.00 (BSE) as of 22-May-2026 13:29 IST. Dr Lal Pathlabs Ltd has given a return of 18.92% in the last 3 years.
What is the current PB & PE ratio of Dr Lal Pathlabs Ltd?
The P/E ratio of Dr Lal Pathlabs Ltd is 54.52 times as on 22-May-2026, a 2 discount to its peers’ median range of 55.79 times.
The P/B ratio of Dr Lal Pathlabs Ltd is 10.97 times as on 22-May-2026, a 31 premium to its peers’ median range of 8.40 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
42.52
|
9.79
|
|
2024
|
52.80
|
10.50
|
|
2023
|
63.80
|
9.48
|
|
2022
|
63.02
|
15.06
|
|
2021
|
77.38
|
18.72
|
What is the 52 Week High and Low of Dr Lal Pathlabs Ltd?
The 52-week high and low of Dr Lal Pathlabs Ltd are Rs 1,770.00 and Rs 1,272.60 as of 22-May-2026.
What is the market cap of Dr Lal Pathlabs Ltd?
Dr Lal Pathlabs Ltd has a market capitalisation of ₹ 27,519 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Dr Lal Pathlabs Ltd?
Before investing in Dr Lal Pathlabs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.